Free Trial
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel
NYSE:PRGO

Perrigo Q3 2026 Earnings Report

Perrigo logo
$14.56 +0.56 (+3.96%)
Closing price 10/7/2026 03:58 PM Eastern
Extended Trading
$14.86 +0.30 (+2.09%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Perrigo EPS Results

Actual EPS
N/A
Consensus EPS
$0.52
Beat/Miss
N/A
One Year Ago EPS
N/A

Perrigo Revenue Results

Actual Revenue
N/A
Expected Revenue
$991.53 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Perrigo Announcement Details

Quarter
Q3 2026
Date
11/4/2026
Time
Before Market Opens
Conference Call Date
Wednesday, November 4, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Perrigo Earnings Headlines

Perrigo (NYSE:PRGO) Cut to Buy at Wall Street Zen
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31053707
Perrigo to Attend the Barclays Global Consumer Conference
August 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/perrigo-to-attend-the-barclays-global-consumer-conference-302860909.html
A dividend every week of the year
Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering real expenses, that rhythm rarely lines up with the bills. Nathan Slaughter, Chief Investment Strategist at High-Yield Investing, built a full 52-week calendar by sequencing quality dividend payers so every week is covered, including bonus dividends that cluster from December through February.tc pixel
 |  Market Savvy (Ad)
Perrigo Company plc
August 24, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/prgo-perrigo-company-plc/vitals
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
August 22, 2026  |  fool.comhttps://www.fool.com/investing/2026/08/22/this-under-the-radar-healthcare-stock-yields-nearl/?source=marketbeat&utm_source=marketbeat&utm_medium=feed&utm_campaign=article&referring_guid=699ea541-1d38-4111-8d93-b9b5f57d6237
Perrigo Co. PLC stock underperforms Tuesday when compared to competitors despite daily gains
August 19, 2026  |  marketwatch.comhttps://www.marketwatch.com/data-news/perrigo-co-plc-stock-underperforms-tuesday-when-compared-to-competitors-despite-daily-gains-7572901d-4a755786cc62
See More Perrigo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Perrigo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Perrigo and other key companies, straight to your email.

About Perrigo

Perrigo (NYSE:PRGO) (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products. Perrigo sells through pharmacies, supermarkets, mass retailers, e-commerce channels and other healthcare outlets.

Founded in 1887 in Allegan, Michigan, Perrigo has expanded from a U.S. supplier of private-label medicines into an international consumer health company. It serves customers across North America, Europe and other global markets, with operations and products tailored to regional consumer and regulatory requirements. Patrick Lockwood-Taylor has served as Perrigo’s president and chief executive officer since 2023.

View Perrigo Profile
Earnings Tools